NUGEN MEDICAL DEVICES INC (NGMD.CA) Stock Earnings & Estimates
Canada - TSX Venture Exchange - TSX-V:NGMD - CA67054F1009 - Common Stock
0.03 CAD
-0.01 (-14.29%)
Full estimates are only available for subscribed users, you can see which data is available below.
Subscribed users also see more surprise data, now it is restricted to 4 quarters.
Examples of complete estimate data are available for MSFT and AAPL.
Registered users have access to more data. Please register or login for additional estimates and surprises .
| 2022 | 2023 | 2024 | ||
|---|---|---|---|---|
| Revenue YoY % growth | 152.4K 10.68% | 331.4K 117.45% | 1.01M 204.74% | |
| EBITDA YoY % growth | -4.142M 39.81% | -7.357M -77.64% | -4.512M 38.68% | |
| EBIT YoY % growth | -4.794M 37.51% | -8.048M -67.88% | -5.158M 35.92% | |
| Operating Margin | -3,145.67% | -2,428.52% | -510.69% | |
| EPS YoY % growth | N/A | N/A | N/A |
All data in CAD
| EPS Q2Q % growth |
|---|
| Revenue Q2Q % growth |
| EBITDA Q2Q % growth |
| EBIT Q2Q % growth |
All data in CAD
| Period | Reported | Estimate | Difference | Surprise |
|---|
| Period | Reported | Estimate | Difference | Surprise |
|---|---|---|---|---|
| Q3 2025 Q2Q % growth | 34.7K -93.47% | % | ||
| Q2 2025 Q2Q % growth | 22.1K 48.32% | % | ||
| Q1 2025 Q2Q % growth | 116.9K 146.62% | % | ||
| Q4 2024 Q2Q % growth | 415.8K 146.47% | % | ||
| Q3 2024 Q2Q % growth | 531.8K 359.24% | % | ||
| Q2 2024 Q2Q % growth | 14.9K -34.07% | % | ||
| Q1 2024 Q2Q % growth | 47.4K 94.26% | % | ||
| Q2 2023 Q2Q % growth | 22.6K -61.56% | % |
| Next Q (1 month) | Next Q (3 month) | Next Year (1 month) | Next Year (3 month) | |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A |
| Revenue | N/A | N/A | N/A | N/A |